Literature DB >> 5382022

[Blood level course in humans following administration of 2 various kinds of L-asparaginase].

J Pütter, G Gehrmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5382022     DOI： 10.1007/bf01484296

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  5 in total

1.  TUMOR INHIBITORY EFFECT OF L-ASPARAGINASE FROM ESCHERICHIA COLI.

Authors:  L T MASHBURN; J C WRISTON
Journal:  Arch Biochem Biophys       Date:  1964-05       Impact factor: 4.013

2.  Partially deaminated L-asparaginase.

Authors:  O Wagner; E Irion; A Arens; K Bauer
Journal:  Biochem Biophys Res Commun       Date:  1969-10-22       Impact factor: 3.575

Review 3.  [Enzyme therapy--a new principle in the management of malignant tumors and hemoblastoses].

Authors:  W M Gallmeier; C G Schmidt
Journal:  Dtsch Med Wochenschr       Date:  1968-04-19       Impact factor: 0.628

4.  Inhibition of leukemias in man by L-asparaginase.

Authors:  H F Oettgen; L J Old; E A Boyse; H A Campbell; F S Philips; B D Clarkson; L Tallal; R D Leeper; M K Schwartz; J H Kim
Journal:  Cancer Res       Date:  1967-12       Impact factor: 12.701

5.  Factors which may influence the effectiveness of L-asparaginases as tumor inhibitors.

Authors:  J D Broome
Journal:  Br J Cancer       Date:  1968-09       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.